Veracyte reported $1.14B in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agenus AGEN:US $ 456.17M 14.87M
Agilent A:US $ 10484M 29M
Anika Therapeutics ANIK:US $ 354.12M 11.88M
Arrowhead Research ARWR:US $ 751.78M 48.21M
Biocept BIOC:US $ 61.94M 1.53M
Bruker BRKR:US $ 3384.8M 165.9M
Exact Sciences EXAS:US $ 6437.16M 53.38M
Heron Therapeutics HRTX:US $ 243.96M 29.76M
Illumina ILMN:US $ 15448M 174M
Immunogen IMGN:US $ 422.3M 59.41M
Intrexon XON:US $ 321.22M 14.34M
Karyopharm Therapeutics KPTI:US $ 256.48M 37.56M
Laboratory Of America LH:US $ 20403.1M 325.3M
Ligand Pharmaceuticals LGND:US $ 1076.29M 28.9M
Myriad Genetics MYGN:US $ 1210.2M 45.2M
Sangamo Biosciences SGMO:US $ 617.13M 37.18M
Siemens SIE:GR € 145988M 2042M
Sonic Healthcare SHL:AU $ 12.55B 87.82M
Thermo Fisher Scientific TMO:US $ 90579M 2168M
Veracyte VCYT:US $ 1144.2M 29.39M
Waters WAT:US $ 3040.57M 0.7M